That's essential, since the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be effective. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (jeff brown 1 biotech company). Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're designed to do. This was a breakthrough almost no one discovered. However it's going to have profound implications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of investment chances in this area, too. Moving topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech genome sequencing). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps significantly before going higher - jeff brown. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mostly educating readers. However that's not the big question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old institution. So think about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. legacy report prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many terrific personal business on the verge of hitting the general public markets And I've been working on a new method for you to invest even prior to these business go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your area for complimentary.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our usual beat (artificial intelligence). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (diplomatic relations). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and predict what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential development and producing unbelievable opportunities for financiers. I want to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown tech stock 2021. However in spite of what lots of readers might think, this is a trend that's simply getting begun. Even though the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff brown stock picks 2021). Losing two months of production and sales actually affects the number of 5G devices are sold in the calendar year. When you think about all of that, offering 250 million systems is remarkable. More importantly, the delays triggered by the pandemic created a load of bottled-up need. Which need is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G gadgets will be delivered in 2021 - social media. Which's not my only 5G prediction When I've spoken about 5G in the past, I've described its three various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Phase 3, 5G services start to be used (biotech stock). That's when we begin to see applications running on 5G networks. Believe of things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summertime. This starts something of a virtuous cycle: Many individuals do not actually appreciate the innovation. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next crucial technology I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR utilizes a similar concept but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For years, CRISPR was primarily a niche technology that wasn't well understood. And during that time, there were truly only 3 business running in this area. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing unbelievable returns. This whole market is efficiently a greenfield chance.
There's space for lots of business to exist in this area. jeff brown genetic sequencing stock. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is essential since the way a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error process. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug treatments produced utilizing this technology. This was one of those breakthroughs that practically no one observed. But it's going to have profound implications for curing disease. And, obviously, there will be lots of financial investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially prior to going greater. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever published was on bitcoin - angel investor. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that initial recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. exponential growth. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date since February 2021, but we might not separately confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional viewpoint on the market. He's always on the hunt for new chances, and he shares a number of his finest picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he effectively anticipated some of the greatest financial events of the past twenty years. Although he doesn't appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, but Jeff Brown's accurate predictions have made him legions of devoted followers. That states a lot about his ability. The Future Report is published by Brownstone Research, a prominent financial research publisher. Brownstone Research offers a number of research study services with a wide range of specializations - angel investor.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - jeff brown biotech stock. On its website, Brownstone says its mission is to provide retail investors with professional-grade research: "For too long, the finest investment research has not been offered to specific financiers. It has actually been generally scheduled for investment banks, hedge funds, personal equity, and high-net-worth clients. black sea. The objective of Brownstone Research is to make that kind of exclusive research offered to any financiers wanting to get an edge in the markets. The objective is basic to provide special and profitable investment research discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise serves as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout the majority of America. If you know even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. jeff brown stock predictions 2021. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown believes S.A.V. jeff brown stock predictions 2021. could be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two advanced technologies: expert system and electrical vehicles. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's nothing except the vehicle market's Holy Grail. As you understand, electrical vehicles and self-driving vehicle stocks have been big this year, however the Wall Street maker has been huge on hype without much concrete outcome. Despite a drastic increase in competition over the past few years, Brown still thinks Musk has the finest opportunity of putting it all together.
tech could be the magic string that connects it all together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transport. Essentially, this innovation would permit you to rent your car as an autonomous, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that informs the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a large chunk of the earnings. It sounds crazy, but it might be closed than you believe.